本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Enlivex Therapeutics Ltd.

0.9595
-0.0212-2.16%
盤後1.000.0405+4.22%19:48 EDT
成交量:25.60萬
成交額:26.04萬
市值:1,677.73萬
市盈率:0.00
高:1.07
開:1.00
低:0.9500
收:0.9807
52周最高:27.15
52周最低:0.9500
股本:1,748.55萬
流通股本:532.27萬
量比:0.98
換手率:4.81%
股息:- -
股息率:- -
每股收益(TTM):382.20
每股收益(LYR):382.20
淨資產收益率:126.17%
總資產收益率:-0.80%
市淨率:0.01
市盈率(LYR):0.00

資料載入中...

2019/06/26

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/06/19

SEC問詢函

[Cover]Correspondence
2019/06/19

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/05/31

超過5%披露

General statement of acquisition of beneficial ownership
2019/05/20

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/30

年度報告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/04/08

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/27

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/18

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/19

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/19

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/31

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/31

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/27

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/21

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/19

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/07/26

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/04/23

年度報告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]